Angela S Kelley1, Yolanda R Smith1, Vasantha Padmanabhan1,2. 1. Department of Obstetrics and Gynecology, University of Michigan, Ann Arbor, Michigan. 2. Department of Pediatrics, University of Michigan, Ann Arbor, Michigan.
Abstract
CONTEXT: Polycystic ovary syndrome (PCOS) is the most common endocrinopathy of reproductive-aged women. In pregnancy, women with PCOS experience increased risk of miscarriage, gestational diabetes, preeclampsia, and extremes of fetal birth weight, and their offspring are predisposed to reproductive and cardiometabolic dysfunction in adulthood. Pregnancy complications, adverse fetal outcomes, and developmental programming of long-term health risks are known to have placental origins. These findings highlight the plausibility of placental compromise in pregnancies of women with PCOS. EVIDENCE SYNTHESIS: A comprehensive PubMed search was performed using terms "polycystic ovary syndrome," "placenta," "developmental programming," "hyperandrogenism," "androgen excess," "insulin resistance," "hyperinsulinemia," "pregnancy," and "pregnancy complications" in both human and animal experimental models. CONCLUSIONS: There is limited human placental research specific to pregnancy of women with PCOS. Gestational androgen excess and insulin resistance are two clinical hallmarks of PCOS that may contribute to placental dysfunction and underlie the higher rates of maternal-fetal complications observed in pregnancies of women with PCOS. Additional research is needed to prevent adverse maternal and developmental outcomes in women with PCOS and their offspring.
CONTEXT: Polycystic ovary syndrome (PCOS) is the most common endocrinopathy of reproductive-aged women. In pregnancy, women with PCOS experience increased risk of miscarriage, gestational diabetes, preeclampsia, and extremes of fetal birth weight, and their offspring are predisposed to reproductive and cardiometabolic dysfunction in adulthood. Pregnancy complications, adverse fetal outcomes, and developmental programming of long-term health risks are known to have placental origins. These findings highlight the plausibility of placental compromise in pregnancies of women with PCOS. EVIDENCE SYNTHESIS: A comprehensive PubMed search was performed using terms "polycystic ovary syndrome," "placenta," "developmental programming," "hyperandrogenism," "androgen excess," "insulin resistance," "hyperinsulinemia," "pregnancy," and "pregnancy complications" in both human and animal experimental models. CONCLUSIONS: There is limited human placental research specific to pregnancy of women with PCOS. Gestational androgen excess and insulin resistance are two clinical hallmarks of PCOS that may contribute to placental dysfunction and underlie the higher rates of maternal-fetal complications observed in pregnancies of women with PCOS. Additional research is needed to prevent adverse maternal and developmental outcomes in women with PCOS and their offspring.
Authors: R Barouki; E Melén; Z Herceg; J Beckers; J Chen; M Karagas; A Puga; Y Xia; L Chadwick; W Yan; K Audouze; R Slama; J Heindel; P Grandjean; T Kawamoto; K Nohara Journal: Environ Int Date: 2018-02-27 Impact factor: 9.621
Authors: Carolina Fux-Otta; Manuel Maliqueo; Bárbara Echiburú; Otilio Rosato; Nicolás Crisosto; Gabriel S Iraci; Marta Fiol de Cuneo; Paula Szafryk de Mereshian; Teresa Sir-Petermann Journal: J Obstet Gynaecol Date: 2018-03-14 Impact factor: 1.246
Authors: M Maliqueo; I Sundström Poromaa; E Vanky; R Fornes; A Benrick; H Åkerud; S Stridsklev; F Labrie; T Jansson; E Stener-Victorin Journal: Hum Reprod Date: 2015-01-20 Impact factor: 6.918
Authors: Christopher R McCartney; Rebecca E Campbell; John C Marshall; Suzanne M Moenter Journal: J Neuroendocrinol Date: 2022-01-26 Impact factor: 3.870